Clinical Trials Sponsored by Shin Poong Pharmaceutical Co. Ltd.

Total 3862 results

Shin Poong Pharmaceutical Co. Ltd.

Completed

Pivotal Study to Evaluate Efficacy and Safety of SP5M001 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis

Osteoarthritis Thumb

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study)

Laparoscopy | Tissue Adhesion, Surgery-Induced | Leiomyoma of the Uterine Body

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Anti-adhesive Effect and Safety of MEDICURTAIN Applied to Undergoing Thyroid Surgery (Pivotal Study)

Tissue Adhesion, Surgery-Induced

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Efficacy and Safety for Medicurtain® in Prevention of Adhesion After Endoscopic Sinus Surgery (Pivotal Study)

Sinusitis | Tissue Adhesion, Surgery-Induced

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

COVID-19

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008

Stroke | Acute Coronary Syndrome

United Kingdom
Shin Poong Pharmaceutical Co. Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SP-8203

Ischemic Stroke

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Recruiting

The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients (PROVIDENCE)

Covid19

Philippines
Shin Poong Pharmaceutical Co. Ltd.

Completed

Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (SP-CAP-002)

Hypertension | Essential Hypertension

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy (Pivotal Study)

Tissue Adhesion, Surgery-Induced | Intrauterine Synechiae

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA (SP-8203-2002)

Ischemic Stroke

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA (SP-8203-2001)

Ischemic Stroke

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

Hypercholesterolemia

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

Healthy

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Active, not recruiting

Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis

Osteoarthritis

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

Hyperlipidemias

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

COVID-19

Korea, Republic of, Colombia, Argentina, Poland, Chile, United Kingdom
Shin Poong Pharmaceutical Co. Ltd.

Completed

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

COVID-19

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Terminated

A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356

Ischemic Stroke | Atherosclerosis

United Kingdom
Shin Poong Pharmaceutical Co. Ltd.

Completed

Spine Surgery for Adhesions in Patients Evaluated for Efficacy and Safety of MedicurtainⓇ (Pivotal Study)

Tissue Adhesion, Surgery-Induced | Intervertebral Disc Disorder | Thoracic Intervertebral Disc Disorders | Thoracolumbar Intervertebral Disc Disorders | Lumbosacral Intervertebral Disc Disorders

Korea, Republic of
Medicines for Malaria Venture
Shin Poong Pharmaceutical Co. Ltd.

Completed

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

Plasmodium Falciparum Malaria

Cambodia, Gambia, Indonesia, Senegal, Thailand, Uganda
Shin Poong Pharmaceutical Co. Ltd.
Medicines for Malaria Venture

Unknown

Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections

Malaria,Falciparum

Gambia, Zambia
Shin Poong Pharmaceutical Co. Ltd.
Medicines for Malaria Venture

Completed

Cohort Event Monitoring Study of Pyramax®

Malaria,Falciparum

Cameroon, Congo, The Democratic Republic of the, Congo, Côte D'Ivoire, Gabon
Medicines for Malaria Venture
Shin Poong Pharmaceutical Co. Ltd.

Completed

Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers

Malaria

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.
Medicines for Malaria Venture

Completed

COVID-19 Treatment in South Africa

COVID-19

South Africa
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate

Malaria

Switzerland
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients

Malaria

Burkina Faso, Congo, The Democratic Republic of the, Kenya, Mali, Mozambique, Philippines, Côte D'Ivoire, Gabon
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Bioequivalence of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet (SP-C-009-07)

Malaria

Switzerland
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine/Artesunate -Ritonavir Drug Drug Interaction Study

Malaria

Switzerland
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Human Mass Balance Study of Pyronaridine

Malaria

Switzerland
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Terminated

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

Malaria

Korea, Republic of
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

Malaria

Congo, The Democratic Republic of the, Gambia, Ghana, Indonesia, Kenya, Mali, Mozambique, Philippines, Senegal
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria

Malaria

Indonesia, Cambodia, India, Thailand
Medicines for Malaria Venture
Shin Poong Pharmaceuticals

Completed

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

Falciparum Malaria

Cambodia, India, Thailand, Burkina Faso, Côte D'Ivoire, Tanzania, Vietnam
Kissei Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.

Completed

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Anemia

Japan
Kissei Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.

Completed

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Anemia

Japan
Kuhnil Pharmaceutical Co., Ltd.
Neurim Pharmaceuticals Ltd.

Completed

Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients

Sleep Initiation and Maintenance Disorders

Korea, Republic of
Kuhnil Pharmaceutical Co., Ltd.
Neurim Pharmaceuticals Ltd.

Completed

Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients

Sleep Initiation and Maintenance Disorders

Korea, Republic of
Ahn-Gook Pharmaceuticals Co.,Ltd
Daehwa Pharmaceutical Co., Ltd.

Not yet recruiting

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Essential Hypertension
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Type 2 Diabetes

United States
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Unknown

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

Type 2 Diabetes Mellitus

United States
Yung Shin Pharm. Ind. Co., Ltd.

Terminated

Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer (VMS)

Breast Cancer | Hot Flashes

Taiwan
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Folds.

Wrinkles Such as Nasolabial Folds

Taiwan
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)

Chemotherapy-induced Nausea and Vomiting, Prophylaxis

Taiwan
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Voriconazole(200mg/Vial) .

Antimycotic for Systematic Use

Taiwan
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Bioequivalence of Two Formulations of Meropenem Intravenous Injection

Healthy
Yung Shin Pharm. Ind. Co., Ltd.

Completed

A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster (Vacyless®)

Herpes Zoster

Taiwan
Tasly GeneNet Pharmaceuticals Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Charcot-Marie-Tooth Type 1A

China
Yung Shin Pharm. Ind. Co., Ltd.

Active, not recruiting

Evaluate Bioequivalence of Burotam (1/1 g/Vial)

Infectious Diseases

Taiwan

Clinical Trials Sponsored by Shin Poong Pharmaceutical Co. Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations